Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Merritt, JA; Roth, JA; Logothetis, CJ
   Clinical evaluation of adenoviral-mediated p53 gene transfer: Review of INGN 201 studies
   SEMINARS IN ONCOLOGY
   
   J.A. Merritt et al., "Clinical evaluation of adenoviral-mediated p53 gene transfer: Review of INGN 201 studies", SEMIN ONCOL, 28(5), 2001, pp. 105-114
2. Yen, N; Ioannides, CG; Xu, K; Swisher, SG; Lawrence, DD; Kemp, BL; El-Naggar, AK; Cristiano, RJ; Fang, BL; Glisson, BS; Hong, WK; Khuri, FR; Kurie, JM; Lee, JJ; Lee, JS; Merritt, JA; Mukhopadhyay, T; Nesbitt, JC; Nguyen, D; Perez-Soler, R; Pisters, KMW; Putnam, JB; Schrump, DS; Shin, DM; Walsh, GL; Roth, JA
   Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53)
   CANCER GENE THERAPY
   
   N. Yen et al., "Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53)", CANC GENE T, 7(4), 2000, pp. 530-536
3. Hobar, PC; Burt, JD; Masson, JA; Merritt, JA; Trawnik, R
   Pericranial flap correction of superior sulcus depression in the anophthalmic orbit
   JOURNAL OF CRANIOFACIAL SURGERY
   
   P.C. Hobar et al., "Pericranial flap correction of superior sulcus depression in the anophthalmic orbit", J CRANIOF S, 10(6), 1999, pp. 487-490
4. Jacobberger, JW; Sramkoski, RM; Zhang, DS; Zumstein, LA; Doerksen, LD; Merritt, JA; Wright, SA; Shults, KE
   Bivariate analysis of the p53 pathway to evaluate Ad-p53 gene therapy efficacy
   CYTOMETRY
   
   J.W. Jacobberger et al., "Bivariate analysis of the p53 pathway to evaluate Ad-p53 gene therapy efficacy", CYTOMETRY, 38(5), 1999, pp. 201-213
5. Swisher, SG; Roth, JA; Nemunaitis, J; Lawrence, DD; Kemp, BL; Carrasco, CH; Connors, DG; El-Naggar, AK; Fossella, F; Glisson, BS; Hong, WK; Khuri, FR; Kurie, JM; Lee, JJ; Lee, JS; Mack, M; Merritt, JA; Nguyen, DM; Nesbitt, JC; Perez-Soler, R; Pisters, KMW; Putnam, JB; Richli, WR; Savin, M; Schrump, DS; Shin, DM; Shulkin, A; Walsh, GL; Wait, J; Weill, D; Waugh, MKA
   Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
   JOURNAL OF THE NATIONAL CANCER INSTITUTE
   
   S.G. Swisher et al., "Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer", J NAT CANC, 91(9), 1999, pp. 763-771
6. CLAYMAN GL; ELNAGGAR AK; LIPPMAN SM; HENDERSON YC; FREDERICK M; MERRITT JA; ZUMSTEIN LA; TIMMONS TM; LIU TJ; GINSBERG L; ROTH JA; HONG WK; BRUSO P; GOEPFERT H
   ADENOVIRUS-MEDIATED P53 GENE-TRANSFER IN PATIENTS WITH ADVANCED RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA
   Journal of clinical oncology
   
   G.L. Clayman et al., "ADENOVIRUS-MEDIATED P53 GENE-TRANSFER IN PATIENTS WITH ADVANCED RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA", Journal of clinical oncology, 16(6), 1998, pp. 2221-2232
7. ROTH JA; SWISHER SG; MERRITT JA; LAWRENCE DD; KEMP BL; CARRASCO CH; ELNAGGAR AK; FOSSELLA FV; GLISSON BS; HONG WK; KHURL FR; KURIE JM; NESBITT JC; PISTERS K; PUTNAM JB; SCHRUMP DS; SHIN DM; WALSH GL
   GENE-THERAPY FOR NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT OF A PHASE-I TRIAL OF ADENOVIRAL P53 GENE REPLACEMENT
   Seminars in oncology
   
   J.A. Roth et al., "GENE-THERAPY FOR NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT OF A PHASE-I TRIAL OF ADENOVIRAL P53 GENE REPLACEMENT", Seminars in oncology, 25(3), 1998, pp. 33-37
8. MERRITT JA; CLAYMAN GL; SWISHER S; NEMUNAITIS J; ELNAGGAR A; GINSBERG L; LAWRENCE D; TIMMONS T; HENDERSON Y; FREDERICK M; CONNORS D; HUTCHISON A; BRUSO P; ROTH JA; SHULKIN A; WEILL D; WAIT J
   CLINICAL-PHASE-I EXPERIENCE WITH INGN-201 (AD-P53) IN NONSMALL CELL LUNG-CANCER AND HEAD AND NECK-CANCER
   Cancer gene therapy
   
   J.A. Merritt et al., "CLINICAL-PHASE-I EXPERIENCE WITH INGN-201 (AD-P53) IN NONSMALL CELL LUNG-CANCER AND HEAD AND NECK-CANCER", Cancer gene therapy, 4(6), 1997, pp. 1-1
9. MERRITT JA; CLAYMAN G; SCHWISHER S; NEMUNAITIS J; ELNAGGAR A; TIMMONS T; LAWRENCE D; KEMP B; FREDERICK M; CONNORS D; BRUSO P; GOEPFERT H; HONG WK; ROTH JA
   CLINICAL GENE-THERAPY STRATEGIES - PHASE-I PHASE-II RESULTS WITH ADENOVIRAL P53 (INGN-201) GENE-TRANSFER IN ADVANCED HEAD AND NECK AND NON-SMALL-CELL LUNG CANCERS/
   Cancer gene therapy
   
   J.A. Merritt et al., "CLINICAL GENE-THERAPY STRATEGIES - PHASE-I PHASE-II RESULTS WITH ADENOVIRAL P53 (INGN-201) GENE-TRANSFER IN ADVANCED HEAD AND NECK AND NON-SMALL-CELL LUNG CANCERS/", Cancer gene therapy, 4(5), 1997, pp. 330-330
10. QUAN WDY; DEAN GE; SPEARS L; SPEARS CP; GROSHEN S; MERRITT JA; MITCHELL MS
    ACTIVE SPECIFIC IMMUNOTHERAPY OF METASTATIC MELANOMA WITH AN ANTIIDIOTYPE VACCINE - A PHASE I II TRIAL OF I-MEL-2 PLUS SAF-M/
    Journal of clinical oncology
    
    W.D.Y. Quan et al., "ACTIVE SPECIFIC IMMUNOTHERAPY OF METASTATIC MELANOMA WITH AN ANTIIDIOTYPE VACCINE - A PHASE I II TRIAL OF I-MEL-2 PLUS SAF-M/", Journal of clinical oncology, 15(5), 1997, pp. 2103-2110
11. LEGER DW; THOMPSON RA; MERRITT JA; BENZ JJ
    ADULT PERCEPTION OF EMOTION INTENSITY IN HUMAN INFANT CRIES - EFFECTSOF INFANT AGE AND CRY ACOUSTICS
    Child development
    
    D.W. Leger et al., "ADULT PERCEPTION OF EMOTION INTENSITY IN HUMAN INFANT CRIES - EFFECTSOF INFANT AGE AND CRY ACOUSTICS", Child development, 67(6), 1996, pp. 3238-3249